Roles of integrins in tumor angiogenesis and lymphangiogenesis.
about
Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesisMVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesionsAngiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradationMechanoinduction of lymph vessel expansion.An in vivo method for visualizing flow dynamics of cells within corneal lymphaticsKallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.Tissue-engineered three-dimensional tumor models to study tumor angiogenesis.Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles.Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.Glycobiology of ocular angiogenesis.Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.The regulation of integrin function by divalent cations.TSC2 modulates cell adhesion and migration via integrin-α1β1Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.Translation initiation: a critical signalling node in cancer.Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part).Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress.Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.Emerging antiangiogenic therapies for non-small-cell lung cancer.Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis.PET radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments.Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin α5β1?Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma.[Cardiac lymphatic system].Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.Association of hOGG1 Ser326Cys, ITGA2 C807T, TNF-A -308G>A and XPD Lys751Gln polymorphisms with the survival of Malaysian NPC patients.Targeting the Tie2-αβ integrin axis with bi-specific reagents for the inhibition of angiogenesis
P2860
Q26863766-2EEA0AC3-07F7-47BC-8F18-0523F70F0A4BQ27331610-4EC124B2-1F61-4222-B1EA-5E6AB797A3E8Q30495730-2A6F7770-2BE1-4CBF-B745-0A0CA842CBF8Q30505376-FF093426-7E34-425E-B652-109D99A19DD8Q30540728-5A759779-F5C5-4AAB-8E4E-02B465AF7284Q33699388-3053E8E4-41E6-4D39-BCD7-95CADCDD5CC2Q33887928-040C2F83-8A1E-4723-AD2F-62B519446F85Q33977444-94036D31-A30B-4433-898F-43A1CED74C81Q34326240-689B0F94-A310-495D-88C4-E7A4A66B0412Q34414227-380EF8F3-79D9-49A2-9385-1E37846A78B2Q35034608-02C2EF8E-B811-43C0-9012-B2AD79ABBED3Q35998499-7061DDFA-EF79-498A-82A8-DC98588F4106Q36312486-C7800774-7C71-4A9B-9AF2-EA93B8E01E86Q36592509-70B928EF-4F1B-4CAD-87E1-3837CF15AC36Q37373141-42B8D105-AC77-47C3-B707-91DF3EB1DAADQ37586472-78540F44-7B52-4428-AF5A-93B30F8014D7Q37600501-A1BBFB05-C18E-4AC9-BEE9-6FB37E1B5BCDQ37612652-140BA965-F1F6-4FB3-9386-6171FADD8883Q37729958-EC206BED-2CC5-4191-A2DF-566E6E67FE85Q37945645-7B7BE4BB-FA30-4EA6-81AC-3B6BE7FA347CQ38207560-E4A04170-8BAA-4FE9-A6CA-BC4FB20F9104Q38228356-D8B7A204-02FB-44F9-872E-10ADA1397871Q38309552-A52DF6B3-1C37-4814-8EEC-82345406ED59Q38942329-7E0F1657-589A-4297-B7BC-F92D5568AFDDQ46264870-A3D80F79-8F45-445A-B24C-22C018BD706BQ47162440-57A1C24C-58A1-491E-8468-8AB98FC64CA5Q49845703-CEAC2D3D-F52A-4DA7-8D02-7B9C1A2FECD7Q54569237-F22580F1-F029-4F28-999D-1BA6E8804A76Q55249241-6CFFD187-3D35-4FFD-8700-B783C851D8E7Q56888898-5DD7F47D-B55F-4021-B929-0412EAF2C40B
P2860
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
@en
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
@nl
type
label
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
@en
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
@nl
prefLabel
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
@en
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
@nl
P2860
P356
P1476
Roles of integrins in tumor angiogenesis and lymphangiogenesis
@en
P2093
Barbara Garmy-Susini
Judith A Varner
P2860
P304
P356
10.1089/LRB.2008.1011
P577
2008-01-01T00:00:00Z